Carries a conserved CRAL-TRIO domain. Its didtant homologs are cytoplasmic and are involved in antiviral response.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 24 |
NetGPI | no | yes: 0, no: 24 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8ICN0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 323 | 327 | PF00656 | 0.220 |
CLV_MEL_PAP_1 | 106 | 112 | PF00089 | 0.409 |
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.453 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 42 | 44 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 61 | 63 | PF00675 | 0.448 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.412 |
CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.419 |
CLV_PCSK_FUR_1 | 151 | 155 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 153 | 155 | PF00082 | 0.462 |
CLV_PCSK_KEX2_1 | 42 | 44 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.448 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.430 |
CLV_PCSK_PC1ET2_1 | 42 | 44 | PF00082 | 0.505 |
CLV_PCSK_PC1ET2_1 | 87 | 89 | PF00082 | 0.417 |
CLV_PCSK_PC7_1 | 83 | 89 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.470 |
CLV_PCSK_SKI1_1 | 313 | 317 | PF00082 | 0.305 |
CLV_PCSK_SKI1_1 | 395 | 399 | PF00082 | 0.308 |
CLV_PCSK_SKI1_1 | 425 | 429 | PF00082 | 0.398 |
CLV_PCSK_SKI1_1 | 437 | 441 | PF00082 | 0.422 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.438 |
CLV_Separin_Metazoa | 257 | 261 | PF03568 | 0.375 |
DEG_COP1_1 | 450 | 460 | PF00400 | 0.255 |
DEG_SCF_FBW7_1 | 198 | 203 | PF00400 | 0.402 |
DEG_SCF_FBW7_2 | 156 | 163 | PF00400 | 0.428 |
DOC_CKS1_1 | 122 | 127 | PF01111 | 0.381 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 306 | 315 | PF00134 | 0.221 |
DOC_CYCLIN_yCln2_LP_2 | 4 | 7 | PF00134 | 0.446 |
DOC_MAPK_gen_1 | 162 | 172 | PF00069 | 0.426 |
DOC_MAPK_gen_1 | 437 | 447 | PF00069 | 0.246 |
DOC_MAPK_gen_1 | 67 | 73 | PF00069 | 0.407 |
DOC_MAPK_MEF2A_6 | 366 | 374 | PF00069 | 0.384 |
DOC_MAPK_MEF2A_6 | 380 | 389 | PF00069 | 0.445 |
DOC_PP1_RVXF_1 | 79 | 85 | PF00149 | 0.379 |
DOC_PP2B_LxvP_1 | 4 | 7 | PF13499 | 0.446 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.431 |
DOC_USP7_MATH_1 | 439 | 443 | PF00917 | 0.310 |
DOC_USP7_UBL2_3 | 380 | 384 | PF12436 | 0.326 |
DOC_WW_Pin1_4 | 101 | 106 | PF00397 | 0.412 |
DOC_WW_Pin1_4 | 121 | 126 | PF00397 | 0.374 |
DOC_WW_Pin1_4 | 156 | 161 | PF00397 | 0.509 |
DOC_WW_Pin1_4 | 188 | 193 | PF00397 | 0.475 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.417 |
LIG_14-3-3_CanoR_1 | 22 | 27 | PF00244 | 0.482 |
LIG_14-3-3_CanoR_1 | 366 | 374 | PF00244 | 0.301 |
LIG_14-3-3_CanoR_1 | 68 | 74 | PF00244 | 0.406 |
LIG_14-3-3_CanoR_1 | 97 | 102 | PF00244 | 0.429 |
LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.401 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.454 |
LIG_eIF4E_1 | 207 | 213 | PF01652 | 0.378 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.414 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.487 |
LIG_FHA_1 | 316 | 322 | PF00498 | 0.304 |
LIG_FHA_1 | 366 | 372 | PF00498 | 0.291 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.470 |
LIG_FHA_2 | 191 | 197 | PF00498 | 0.468 |
LIG_FHA_2 | 483 | 489 | PF00498 | 0.658 |
LIG_GBD_Chelix_1 | 230 | 238 | PF00786 | 0.298 |
LIG_LIR_Apic_2 | 292 | 297 | PF02991 | 0.242 |
LIG_LIR_Gen_1 | 127 | 137 | PF02991 | 0.372 |
LIG_LIR_Gen_1 | 206 | 213 | PF02991 | 0.281 |
LIG_LIR_LC3C_4 | 115 | 119 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 127 | 132 | PF02991 | 0.376 |
LIG_LIR_Nem_3 | 175 | 180 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 206 | 212 | PF02991 | 0.348 |
LIG_LIR_Nem_3 | 339 | 345 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 378 | 382 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 396 | 401 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 418 | 424 | PF02991 | 0.354 |
LIG_MYND_1 | 3 | 7 | PF01753 | 0.446 |
LIG_NRBOX | 183 | 189 | PF00104 | 0.402 |
LIG_NRBOX | 332 | 338 | PF00104 | 0.213 |
LIG_PCNA_PIPBox_1 | 329 | 338 | PF02747 | 0.276 |
LIG_Pex14_1 | 342 | 346 | PF04695 | 0.314 |
LIG_Pex14_2 | 110 | 114 | PF04695 | 0.411 |
LIG_SH2_CRK | 177 | 181 | PF00017 | 0.416 |
LIG_SH2_CRK | 209 | 213 | PF00017 | 0.328 |
LIG_SH2_CRK | 294 | 298 | PF00017 | 0.295 |
LIG_SH2_CRK | 421 | 425 | PF00017 | 0.333 |
LIG_SH2_STAT3 | 232 | 235 | PF00017 | 0.394 |
LIG_SH2_STAT3 | 345 | 348 | PF00017 | 0.261 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 283 | 286 | PF00017 | 0.400 |
LIG_SH2_STAT5 | 300 | 303 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 456 | 459 | PF00017 | 0.319 |
LIG_SH3_1 | 31 | 37 | PF00018 | 0.491 |
LIG_SH3_2 | 37 | 42 | PF14604 | 0.499 |
LIG_SH3_2 | 7 | 12 | PF14604 | 0.449 |
LIG_SH3_3 | 116 | 122 | PF00018 | 0.407 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.491 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.446 |
LIG_SH3_3 | 408 | 414 | PF00018 | 0.332 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.414 |
LIG_SUMO_SIM_anti_2 | 115 | 120 | PF11976 | 0.414 |
LIG_SUMO_SIM_anti_2 | 442 | 450 | PF11976 | 0.339 |
LIG_SUMO_SIM_par_1 | 368 | 373 | PF11976 | 0.313 |
LIG_TYR_ITIM | 298 | 303 | PF00017 | 0.376 |
LIG_UBA3_1 | 311 | 316 | PF00899 | 0.336 |
LIG_WRC_WIRS_1 | 416 | 421 | PF05994 | 0.230 |
LIG_WW_2 | 7 | 10 | PF00397 | 0.444 |
MOD_CDK_SPxK_1 | 156 | 162 | PF00069 | 0.433 |
MOD_CK1_1 | 191 | 197 | PF00069 | 0.352 |
MOD_CK1_1 | 246 | 252 | PF00069 | 0.456 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.490 |
MOD_CK1_1 | 415 | 421 | PF00069 | 0.490 |
MOD_CK1_1 | 482 | 488 | PF00069 | 0.479 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.470 |
MOD_CK2_1 | 302 | 308 | PF00069 | 0.369 |
MOD_CK2_1 | 491 | 497 | PF00069 | 0.661 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.447 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.450 |
MOD_GlcNHglycan | 245 | 248 | PF01048 | 0.468 |
MOD_GlcNHglycan | 338 | 341 | PF01048 | 0.237 |
MOD_GlcNHglycan | 481 | 484 | PF01048 | 0.615 |
MOD_GlcNHglycan | 493 | 496 | PF01048 | 0.692 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.436 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.474 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.483 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.402 |
MOD_GSK3_1 | 389 | 396 | PF00069 | 0.495 |
MOD_GSK3_1 | 479 | 486 | PF00069 | 0.739 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.480 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.425 |
MOD_N-GLC_1 | 201 | 206 | PF02516 | 0.300 |
MOD_NEK2_1 | 375 | 380 | PF00069 | 0.373 |
MOD_NEK2_1 | 389 | 394 | PF00069 | 0.386 |
MOD_NEK2_2 | 393 | 398 | PF00069 | 0.204 |
MOD_NEK2_2 | 69 | 74 | PF00069 | 0.404 |
MOD_PIKK_1 | 164 | 170 | PF00454 | 0.415 |
MOD_PIKK_1 | 489 | 495 | PF00454 | 0.502 |
MOD_PKA_1 | 67 | 73 | PF00069 | 0.407 |
MOD_PKA_2 | 266 | 272 | PF00069 | 0.476 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.490 |
MOD_PKA_2 | 365 | 371 | PF00069 | 0.340 |
MOD_PKA_2 | 67 | 73 | PF00069 | 0.407 |
MOD_Plk_4 | 366 | 372 | PF00069 | 0.341 |
MOD_Plk_4 | 393 | 399 | PF00069 | 0.499 |
MOD_Plk_4 | 412 | 418 | PF00069 | 0.270 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.404 |
MOD_ProDKin_1 | 101 | 107 | PF00069 | 0.414 |
MOD_ProDKin_1 | 121 | 127 | PF00069 | 0.373 |
MOD_ProDKin_1 | 156 | 162 | PF00069 | 0.502 |
MOD_ProDKin_1 | 188 | 194 | PF00069 | 0.480 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.410 |
MOD_SUMO_for_1 | 278 | 281 | PF00179 | 0.250 |
MOD_SUMO_rev_2 | 157 | 167 | PF00179 | 0.415 |
MOD_SUMO_rev_2 | 308 | 318 | PF00179 | 0.219 |
TRG_DiLeu_BaEn_1 | 443 | 448 | PF01217 | 0.310 |
TRG_DiLeu_BaLyEn_6 | 102 | 107 | PF01217 | 0.410 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.508 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.419 |
TRG_ENDOCYTIC_2 | 209 | 212 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 300 | 303 | PF00928 | 0.384 |
TRG_ENDOCYTIC_2 | 346 | 349 | PF00928 | 0.460 |
TRG_ENDOCYTIC_2 | 379 | 382 | PF00928 | 0.309 |
TRG_ENDOCYTIC_2 | 421 | 424 | PF00928 | 0.333 |
TRG_ER_diArg_1 | 150 | 153 | PF00400 | 0.531 |
TRG_ER_diArg_1 | 60 | 62 | PF00400 | 0.464 |
TRG_ER_diArg_1 | 66 | 68 | PF00400 | 0.417 |
TRG_ER_diArg_1 | 81 | 84 | PF00400 | 0.376 |
TRG_ER_diArg_1 | 88 | 90 | PF00400 | 0.428 |
TRG_NLS_MonoCore_2 | 86 | 91 | PF00514 | 0.413 |
TRG_NLS_MonoExtC_3 | 29 | 34 | PF00514 | 0.492 |
TRG_NLS_MonoExtN_4 | 27 | 34 | PF00514 | 0.489 |
TRG_Pf-PMV_PEXEL_1 | 260 | 265 | PF00026 | 0.442 |
TRG_Pf-PMV_PEXEL_1 | 89 | 94 | PF00026 | 0.403 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6D4 | Leptomonas seymouri | 36% | 95% |
A0A0N0P991 | Leptomonas seymouri | 30% | 100% |
A0A0N1PCS4 | Leptomonas seymouri | 66% | 100% |
A0A0S4KJL3 | Bodo saltans | 26% | 100% |
A0A3Q8IGQ2 | Leishmania donovani | 30% | 100% |
A0A3S7X4P4 | Leishmania donovani | 39% | 96% |
A0A3S7X4R1 | Leishmania donovani | 51% | 100% |
A4HJI7 | Leishmania braziliensis | 40% | 100% |
A4HJI8 | Leishmania braziliensis | 51% | 100% |
A4HJI9 | Leishmania braziliensis | 77% | 100% |
A4HKB3 | Leishmania braziliensis | 30% | 100% |
A4I6Y2 | Leishmania infantum | 40% | 100% |
A4I6Y3 | Leishmania infantum | 51% | 100% |
A4I6Y4 | Leishmania infantum | 99% | 100% |
A4I7U3 | Leishmania infantum | 30% | 100% |
E9B204 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 100% |
E9B205 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 54% | 100% |
E9B206 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
E9B2Q1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
Q4Q5F6 | Leishmania major | 30% | 100% |
Q4Q655 | Leishmania major | 86% | 100% |
Q4Q656 | Leishmania major | 50% | 100% |
Q4Q657 | Leishmania major | 38% | 100% |
Q92503 | Homo sapiens | 21% | 70% |